Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122357072 | 12235707 | 2 | F | 20160729 | 20160404 | 20160812 | EXP | 2015M1010089 | CA-HQ SPECIALTY-CA-2016INT000158 | INTERCHEM | 61.00 | YR | F | Y | 0.00000 | 20160812 | CN | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122357072 | 12235707 | 1 | PS | METHOTREXATE SODIUM. | METHOTREXATE SODIUM | 1 | Unknown | 3.5714 MG (25 MG,1 IN 1 W) | 201749 | ||||||||||
| 122357072 | 12235707 | 2 | SS | ARAVA | LEFLUNOMIDE | 1 | Unknown | (20 MG,1 D) | N | 0 | |||||||||
| 122357072 | 12235707 | 3 | SS | REMICADE | INFLIXIMAB | 1 | Unknown | 5.3571 MG (300 MG,1 IN 8 W) | N | 0 | |||||||||
| 122357072 | 12235707 | 4 | SS | RITUXAN | RITUXIMAB | 1 | Unknown | UNK | N | 0 | |||||||||
| 122357072 | 12235707 | 5 | SS | XELJANZ | TOFACITINIB CITRATE | 1 | Oral | 10 MG (5 MG, 2 IN 1 D) | 0 | ||||||||||
| 122357072 | 12235707 | 6 | SS | ACTEMRA | TOCILIZUMAB | 1 | Unknown | (8 MG/KG) | N | 0 | |||||||||
| 122357072 | 12235707 | 7 | SS | CIMZIA | CERTOLIZUMAB PEGOL | 1 | Unknown | (200 MG) | N | 0 | |||||||||
| 122357072 | 12235707 | 8 | SS | ORENCIA | ABATACEPT | 1 | Unknown | 25 MG (750 MG,1 IN 1 MO) | N | 0 | |||||||||
| 122357072 | 12235707 | 9 | SS | SIMPONI | GOLIMUMAB | 1 | Unknown | 1.6667 MG (50 MG,1 IN 1 MO) | N | 0 | |||||||||
| 122357072 | 12235707 | 10 | C | INSULIN | INSULIN NOS | 1 | Oral | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 122357072 | 12235707 | 1 | Rheumatoid arthritis |
| 122357072 | 12235707 | 2 | Rheumatoid arthritis |
| 122357072 | 12235707 | 3 | Rheumatoid arthritis |
| 122357072 | 12235707 | 4 | Rheumatoid arthritis |
| 122357072 | 12235707 | 5 | Rheumatoid arthritis |
| 122357072 | 12235707 | 6 | Product used for unknown indication |
| 122357072 | 12235707 | 7 | Product used for unknown indication |
| 122357072 | 12235707 | 8 | Product used for unknown indication |
| 122357072 | 12235707 | 9 | Product used for unknown indication |
| 122357072 | 12235707 | 10 | Diabetes mellitus |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 122357072 | 12235707 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122357072 | 12235707 | Drug ineffective | |
| 122357072 | 12235707 | Headache | |
| 122357072 | 12235707 | Insomnia | |
| 122357072 | 12235707 | Memory impairment | |
| 122357072 | 12235707 | Pain | |
| 122357072 | 12235707 | Swelling |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 122357072 | 12235707 | 1 | 200902 | 0 | ||
| 122357072 | 12235707 | 2 | 200907 | 201102 | 0 | |
| 122357072 | 12235707 | 3 | 201002 | 201103 | 0 | |
| 122357072 | 12235707 | 4 | 2014 | 0 | ||
| 122357072 | 12235707 | 5 | 20150331 | 0 | ||
| 122357072 | 12235707 | 6 | 201108 | 201111 | 0 | |
| 122357072 | 12235707 | 7 | 20110913 | 201202 | 0 | |
| 122357072 | 12235707 | 8 | 20120308 | 20150902 | 0 | |
| 122357072 | 12235707 | 9 | 201305 | 20131209 | 0 |